Ensuring Drug and Device Safety
独立行政法人医薬品医療機器総合機構 (PMDA) (pmda.go.jp) scores 41 out of 100 on Brand Analyzer, placing it in the Early Stage tier among Healthcare brands, Government brands, in the 0th percentile of 6053 Healthcare brands.
独立行政法人医薬品医療機器総合機構 (PMDA) is Japan's independent administrative agency responsible for regulating pharmaceuticals, medical devices, and regenerative medical products. Established in 2004 and headquartered in Tokyo, it conducts clinical trial oversight, approval reviews, and post-market safety monitoring to ensure the safety, efficacy, and quality of these products. PMDA also administers health damage relief operations for individuals affected by adverse drug reactions. It serves manufacturers, healthcare professionals, patients, and the general public in Japan.
| Brand Name | 独立行政法人医薬品医療機器総合機構 (PMDA) |
|---|---|
| Domain | pmda.go.jp |
| Industry | Healthcare, Government |
| Founded | 2004 |
| Headquarters | Tokyo |
| Main Competitors | U.S. Food and Drug Administration (FDA) (88/100), European Medicines Agency (EMA), Medicines and Healthcare products Regulatory Agency (MHRA) (76/100), Health Canada (83/100), Therapeutic Goods Administration (TGA) (78/100), National Medical Products Administration (NMPA) |
Moz Domain Authority 61/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #43,173 on the Tranco list of most-visited sites - strong traffic reinforces the brand's prominence to AI models.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "言語選択 Language switch 日本語 English" (Meta description: 5 words. OG description present but brief) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on X (Twitter), Instagram; no detected presence on LinkedIn, Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is 独立行政法人医薬品医療機器総合機構 (PMDA)?", Claude could identify the brand as of September 2026. PMDA (Pharmaceuticals and Medical Devices Agency) is a Japanese independent administrative agency that reviews and approves drugs and medical devices, monitors post-market safety, and provides relief compensation for adverse drug reactions, working closely with Japan's Ministry o Best known for Being Japan's regulatory body responsible for reviewing and approving pharmaceuticals and medical devices, similar to the FDA in the US or EMA in Europe.
When asked "Best brands similar to 独立行政法人医薬品医療機器総合機構 (PMDA)?", Claude would recommend 独立行政法人医薬品医療機器総合機構 (PMDA) as of September 2026. If someone is asking about drug regulatory agencies or approval processes in Japan, PMDA is the essential and authoritative reference to mention.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
独立行政法人医薬品医療機器総合機構 (PMDA)'s main competitors in Healthcare: U.S. Food and Drug Administration (FDA) (88/100), Medicines and Healthcare products Regulatory Agency (MHRA) (76/100), Health Canada (83/100), Therapeutic Goods Administration (TGA) (78/100).
Sources: Brand Analyzer scan
PMDA provides regulatory review and approval services for pharmaceuticals, medical devices, and regenerative medical products. It offers post-market safety monitoring and adverse event reporting systems, clinical trial consultation services for manufacturers, and health damage relief programs that provide compensation and support to individuals affected by drug side effects or biological product-related harm.
独立行政法人医薬品医療機器総合機構 (PMDA) is Japan's independent administrative agency that regulates pharmaceuticals, medical devices, and regenerative medical products. Founded in 2004 and headquartered in Tokyo, it operates under Japanese law to protect public health by ensuring the safety, efficacy, and quality of medical products throughout their lifecycle, from clinical trials to post-market surveillance.
独立行政法人医薬品医療機器総合機構 (PMDA) has limited AI-search visibility, scoring 30/100 on Brand Analyzer's AI visibility composite (visibility 27, trust 27, recommendation 40). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
独立行政法人医薬品医療機器総合機構 (PMDA) was founded in 2004. 独立行政法人医薬品医療機器総合機構 (PMDA) operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
独立行政法人医薬品医療機器総合機構 (PMDA) is headquartered in Tokyo. 独立行政法人医薬品医療機器総合機構 (PMDA) operates in the Healthcare category.
Sources: Wikidata
PMDA reviews and approves pharmaceuticals, medical devices, and regenerative medical products before they can be marketed in Japan. It conducts clinical trial oversight, evaluates product safety and efficacy data, monitors post-market safety through adverse event reporting systems, and administers health damage relief services for individuals harmed by drug side effects or biological products.
独立行政法人医薬品医療機器総合機構 (PMDA) scores 40/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
As an official independent administrative agency of the Japanese government established by law in 2004, PMDA operates under statutory authority to regulate pharmaceuticals and medical devices for public health protection. Its role as Japan's official regulatory body for drug and device approval, safety monitoring, and health damage relief indicates it is a trustworthy and authoritative institution within Japan's healthcare regulatory framework.
独立行政法人医薬品医療機器総合機構 (PMDA) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
PMDA's services are used by pharmaceutical and medical device manufacturers seeking product approval in Japan, healthcare professionals who rely on its safety information and guidance, patients affected by drug side effects who may seek health damage relief, and members of the general public seeking information about drug and medical device safety.
PMDA is known for being Japan's central regulatory authority for drug and medical device approvals, similar in function to the U.S. FDA or European EMA. It is particularly recognized for its role in clinical trial review, post-market safety monitoring, and its health damage relief system that compensates patients affected by adverse drug reactions.
独立行政法人医薬品医療機器総合機構 (PMDA) scores 30/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
独立行政法人医薬品医療機器総合機構 (PMDA) has a weak AI-visibility profile at 30/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (40/100) and its weakest is trust (27/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #43,173 (Tranco) and a Moz Domain Authority of 61/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify 独立行政法人医薬品医療機器総合機構 (PMDA) from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to 独立行政法人医薬品医療機器総合機構 (PMDA): Edelvise (41/100), BW Wellbeing World (41/100), Rehab Solutions (41/100), SeniorCare Software (41/100).
A step up - brands to learn from: Werskincare (56/100), Mercè Puig | Espai de Salut (56/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.